Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi Dupixent gets Japenese nod for chronic spontaneous urticaria

Written By Ruchika Sharma18 Feb 2024 10:00 AM IST

Paris: Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche Xolair gets USFDA nod for children, adults with one or more food allergies

Written By Ruchika Sharma17 Feb 2024 4:30 PM IST

In the U.S., Genentech, a member of the Roche Group, and Novartis Pharmaceuticals Corporation work together to develop and co-promote Xolair.

Global Fund expands commitment to improve access to HIV drug

Gilead Sciences pauses enrollment globally in magrolimab solid tumor studies

Written By Ruchika Sharma17 Feb 2024 2:43 PM IST

Foster City: Gilead Sciences, Inc. has announced that it has paused enrollment globally in the magrolimab solid tumor studies. The U.S. Food and Drug...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca Tagrisso with chemotherapy approved in US for EGFR-mutated advanced lung cancer

Written By Ruchika Sharma17 Feb 2024 12:00 PM IST

Tagrisso (osimertinib) is a third-generation, irreversible EGFR-TKI with proven clinical activity in NSCLC, including against CNS metastases.

Zydus Lifesciences secures USFDA okay for angina drug Isosorbide Mononitrate ER

Written By Ruchika Sharma16 Feb 2024 3:52 PM IST

Ahmedabad: Pharma major Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Lupin bags USFDA nod for pregnancy prevention drug Minzoya

Written By Ruchika Sharma16 Feb 2024 3:02 PM IST

Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy.

Sun Pharma unit Taro recalls over 17k units of antifungal medication in US

Philips recall of imaging machines classified as most serious by USFDA

Written By Ruchika Sharma16 Feb 2024 1:30 PM IST

There has been one incident related to use of the device, but no reports of injuries or deaths, the FDA said.

Cipla Gets 2 USFDA Observations for Goa Facility

Cipla, CSIR-CDRI to jointly develop novel ophthalmic formulation for fungal keratitis

Written By Ruchika Sharma16 Feb 2024 12:30 PM IST

Mumbai: Cipla Limited has announced that the company has entered into a collaborative research agreement with CSIR-Central Drug Research Institute...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin unveils Ganirelix Acetate Injection in US

Written By Ruchika Sharma16 Feb 2024 11:24 AM IST

It is indicated for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation.

Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk

Pfizer agrees to pay USD 93 million to settle cholesterol drug Lipitor antitrust lawsuit

Written By Ruchika Sharma15 Feb 2024 2:16 PM IST

Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

Bristol Myers Squibb application for Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid Tumors accepted by USFDA for priority review

Written By Ruchika Sharma15 Feb 2024 11:13 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug...

CDSCO approves Jardiance for treatment of adults with chronic kidney disease in India

Written By Ruchika Sharma14 Feb 2024 5:49 PM IST

Mumbai: The national regulatory authority of India, the Central Drugs Standard Control Organisation (CDSCO), has approved Jardiance...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok